Satsuma Pharmaceuticals, Inc. STSA
Set alert
1.10 +1.10 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 36.80M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -1.29
- Beta
- 0.10
- Short ratio
- 0.05
- Inst. own
- 57.90%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 11, 2023
- 50-d avg
- 0.991336
- 200-d avg
- 2.18
- 1y target
- 2.00
Financial health
Altman Z-Score
-7.32 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.4×
FY 2017 5y median -2.6× FY 2022
P/S 0.0×
FY 2017 5y median 0.0× FY 2022
P/B -0.1×
FY 2017 5y median -0.9× FY 2022
P/FCF -0.6×
FY 2017 5y median -2.9× FY 2022
EV/EBITDA -0.2×
FY 2017 5y median -2.3× FY 2022
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2022
FCF Yield -180.4%
FY 2017 5y median -34.3% FY 2022
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2022
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2022
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2022
ROE 32.7%
FY 2017 5y median 52.6% FY 2022
ROIC -149.1%
FY 2017 5y median -64.5% FY 2022
ROA -125.9%
FY 2017 5y median -58.8% FY 2022
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2022
Operating Income -38.7%
FY 2017 FY 2022
EPS (diluted) -22.7%
FY 2017 FY 2022
Free Cash Flow -15.5%
FY 2017 FY 2022
Financial Health
Current Ratio 6.8×
FY 2017 5y median 9.2× FY 2022
Quick Ratio 6.8×
FY 2017 5y median 9.2× FY 2022
Debt / Equity -0.0×
FY 2017 5y median -0.0× FY 2022
Net Debt / EBITDA 0.2×
FY 2017 5y median 0.3× FY 2022
Interest Coverage -5457×
FY 2017 5y median -138× FY 2022
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31